Orchid Pharma Limited has informed the Exchange regarding a press release dated May 23, 2024, titled "Orchid Pharma announces Q4 results with 71.60% growth in annual PAT".
Orchid Pharma Limited has informed the Exchange regarding a press release dated May 23, 2024, titled "Orchid Pharma announces Q4 results with 71.60% growth in annual PAT".